Rossiiskii immunologicheskii zhurnalIssue 4Diagnostic and Prognostic Significance of Soluble Cell Adhesion Molecules in Typical Hemolytic Uremic Syndrome
views: 825
Readers community rating: votes 0
1. Shpikalova I. Yu., Pankratenko T. E., Ehmirova Kh. M., Zvereva D. V., Tolstova E. M. Porazhenie TsNS u bol'nykh s shiga-toksin assotsiirovannym gemolitiko-uremicheskim sindromom (STET-GUS): sovremennye aspekty patogeneza, klinika i strategiya lecheniya (obzor literatury). Nefrologiya i dializ 2014, T. 16, № 1,150–154. [Shpikalova I. Ju., Pankratenko T. E., Jemirova H. M., Zvereva D. V., Tolstova E. M. Neurological involvement in patients with STEC-Associated Hemolytic Uremic Syndrome (STEC-HUS): modern aspects of pathogenesis, clinical features and treatment modalities. Nephrology and Dialysis 2014, Vol.16, No 1, 150–154].
2. Ehmirova Kh. M., Tolstova E. M., Kagan M. Yu., Orlova O. M., Abaseeva T. Yu., Pankratenko T. E., Shpikalova I. Yu. Gemolitiko-uremicheskij sindrom, assotsiirovannyj s shiga-toksin-produtsiruyuschej Escherichia coli. Nefrologiya 2016, T. 20, № 2, 18–32. [Jemirova H. M., Tolstova E. M., Kagan M. Ju., Orlova O. M., Abaseeva T. Ju., Pankratenko T. E., Shpikalova I. Ju. Hemolytic uremic syndrome associated with shiga-toxin-producing Escherichia coli. Nephrology 2016, Vol.20. No 2, 18–32].
3. Page A. V., Liles C. W. Biomarkers of endothelial activation/ dysfunction in infectious disease. Virulence 2013, V.4(6), 507–516.
4. Talarico V., Aloe M., Monzani A., Miniero R., Bona G. Hemolytic uremic syndrome in children. Minerva Pediatr. 2016, V.68(6), 441–445.
5. Videm V., Albrigsten M. Soluble ICAM-1 and VCAM-1 as markers of endothelial activation. Scand. J. Immunol. 2007, V. 67, 523–531.
